Top of this page
Skip navigation, go straight to the content Newsroom UCB U.S. News


  • Patients Propel Scientific Discovery

    Posted by Katelyn Snider, U.S. Communications and Public Affairs
    Patients are at the heart of everything we do, inspiring us, driving our scientific discovery, and focusing us on what patients value. At UCB, we want to help people live their best lives, whatever that means for them. So, every day, we come together to work, laser-focused, on a simple question: How will this create value for people living with severe diseases?

    Read more

  • Growing our Footprint in Boston and Seattle

    Posted by Katelyn Snider, U.S. Communications and Public Affairs
    In 2019, we look forward to continuing our journey to grow our impact. Our future has never been brighter and the opportunities to provide patients with solutions they value has never been more urgent. By fulfilling our commitment, driving innovation, and providing patients a meaningful experience, solutions are on the horizon to help more patients managing severe diseases live their best lives.

    Read more

  • UCB Hosts Patients to Share the Art of Advocacy

    Posted by Becky Malone, Engagement and Communications Specialist
    In September, our Raleigh-Durham office hosted their first Art of Advocacy event, which explored how art can be used as a platform for advocacy. The event showcased three artists, from across the U.S., living with a chronic illness, who use art as a medium to cope, spread awareness, and encourage others. We invite you to meet them and learn more about their stories below.

    Read more

  • UCB-UNC-Duke Neurology Clinical Development Program

    Posted by Katelyn Snider, U.S. Communications and Public Affairs

    (Left to Right) Dr. Michael Markowitz (UCB), Dr. Shruti Raja, and Dr. Robert Dupuis (UNC Eshelman School of Pharmacy)

    An important part of the drug development continuum is ensuring trained specialists are engaged through discovery, development, and delivery. Neurotherapeutics, or treatment of disorders of the nervous system, is a research area with a limited number of highly trained neurologists working in drug development. To help fill this gap, the UCB-UNC-Duke Neurology Clinical Development Fellowship program was developed for board certified neurologists seeking further training in neurology drug development.

    Read more

  • UCB’s Eddy Han-Burgess Leverages Data to Improve Patient Lives

    Posted by Katelyn Snider, U.S. Communications and Public Affairs
    Eddy_Han Burgess_1280x960
    Edward (Eddy) Han-Burgess, UCB’s Epilepsy Prediction and Integrated Analytics Lead, is featured in a researcher profile on talking about his work leveraging data and mathematics to improve the lives of those living with epilepsy.

    Read more

  • UCB researcher, Henrik Klitgaard, Featured in PhRMA’s GOBOLDLY Campaign

    Posted by Allyson Funk, Head of U.S. Communications and Public Relations
    Throughout November, Epilepsy Awareness Month, we’re shining a spotlight on epilepsy, a severe neurological disease that 1 in 26 people will develop in their lifetime.

    Read more

  • UCB PharmD Fellowship Program Accepting Applications

    Posted by Katelyn Snider, U.S. Communications and Public Affairs

    Fellowship Preceptors (L to R): Oana Pop, Iram Hasan, Alexis Harper, Wanja Muthoga, Kate Kocik, Jennifer King, and Tanyja Porcha

    UCB is now accepting applications for our 2019-2021 Global Regulatory Affairs PharmD Fellowship Program through December 1, 2018.

    Read more

  • Supporting the Next Generation of Scientists

    Posted by Becky Malone, Engagement and Communications SpecialistAEN_photo_1280x960
    Today, our Research Triangle Park office in Raleigh, North Carolina hosted its fifth annual Academic Engagement Night.

    Read more

  • ICYMI: UCB in the News

    Posted by Katelyn Snider, U.S. Communications and Public AffairsBlog_Photo_1280x960

    At UCB, we strive to discover and deliver new solutions patients value. Whether it’s through leveraging big data, thinking outside the box to overcome barriers, or collaborating with others in the healthcare industry—initiatives across UCB are at the forefront of research, and recently, our experts have been in the news talking about what we’re working on.

    Read more

  • UCB Runners Lace Up to Support Patients

    Posted by Katelyn Snider, U.S. Communications and Public Affairs9q0ipi0055.gif

    UCB supports local events across the country that benefit patients. Recently, our employees participated in two different runs in support of the epilepsy and Crohn’s disease communities.

    Read more